Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "Developments in Digital Biomanufacturing: Technology Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
The report analyzes the progress that the biomanufacturing industry has made in terms of digitalization and how the industry embraces technological advancement to lower its biomanufacturing footprint and overcome the limitations of traditional methods.
Digitalization of the entire value chain will drive next-generation biomanufacturing. The industry is all set to move away from the traditional pen-and-paper-based process to a more advanced, digitized, a track-and-trace process that is aligned toward Industry 4.0.
Digital tools applied across processes, monitoring, analytics, and operations have accelerated biomanufacturing with a data-driven approach. Digital biomanufacturing can streamline processes and assist with the optimal use of resources.
Scalability and reproducibility are some of the crucial challenges in biomanufacturing, especially in the production of biologics, and cell and gene therapies, or viral vector manufacturing. Digitalization is enabling a sustainable, effective, cost-efficient, time-efficient, and error-free system for biomanufacturing.
IoT, automation/robotics, AI/machine learning, Digital Twins, and Blockchain have been deployed in various digital biomanufacturing processes, thereby ensuring a seamless and uninterrupted workflow. Digitalization enables the best control and optimization of starting materials; in upstream processes, it helps with cell culture and media optimization; for downstream processes, it helps select the best strategy for purification and impurity removal.
Digital tools are also making the best use of historical biomanufacturing data to improve/optimize processes. Advanced sensors and cutting-edge software collect real-time data, which offers a complete picture of the bioreactor's condition.
Advanced analytics helps users understand variations in data and predict the most suitable conditions for the biomanufacturing of therapeutics. Digital tools and powerful software platforms empower scientists and engineers and help them offer better-quality, sustainable products to patients faster and at a lower cost.
Key Topics Covered:
1. Strategic Imperatives
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative: Factors Creating Pressure on Digital Biomanufacturing Growth
The Impact of the Top 3 Strategic Imperatives on the Digital Biomanufacturing Industry
Growth Opportunities Fuel the Growth Pipeline Engine
2. Growth Environment Analysis
Scope of Analysis
3. Assessment of Digital Biomanufacturing Technologies
Benefits of Deploying Digital Biomanufacturing
Shift Toward a Full- Fledged Digitally Equipped Biomanufacturing Unit
Technology Convergence for Seamless Digital Biomanufacturing
Digitalization Increases Bioproduct Quality and Quantity
Application of Digital Biomanufacturing in Developing Therapeutics
Automation & Robotics
IoT and Cloud
4. Process Control/Optimization
Data-driven Process Control and Optimization
Wide Adoption of Cell Culture Automation and Optimization in Upstream Processes
Shift Toward Continuous Biomanufacturing for Downstream Processes
Industry Stakeholders Optimizing Upstream and Downstream Processes for a Smooth Transformation
5. Process Analytics & Monitoring
Advanced Analytics for Biomanufacturing Data
Advanced Analytical System to Monitor Biomanufacturing
Advancements in Digital Analytical Tools for Real-Time Product Quality Check
New Approaches in Advanced Process Analytics
Predictive Approaches to Lead the Way Forward for Biomanufacturing
6. Factory Operations
Digital Solution to Enable Efficient Factory Outcomes and Operational Challenges
Transformation to a Full-Fledged Digital Factory Operation Systems
Companies Improving the Entire Manufacturing Operations Digitally
Collaboration between CDMOs and Biopharma to Increase Digitization of Biomanufacturing
7. Supply Chain
Digital Solution to Improve Supply Chain
Digital Supply Chain Increases Transparency and Interaction
Blockchain Creating Safe and Well-covered Network for Supply Chain
The Path Ahead
8. Adoption and Implementation of Digital Tools
Encouraging Funding Activities for the Adoption of Digital Biomanufacturing
Collaborations for Implementation of Digital Biomanufacturing
Company Categorization Based on Digital Biomanufacturing Capabilities
9. Growth Opportunity Universe
Growth Opportunity 1: Adoption of Digital Twins
Growth Opportunity 2: Incorporation of Predictive Analytics
Growth Opportunity 3: Targeted Acquisitions
10. Next Steps
For more information about this report visit https://www.researchandmarkets.com/r/4y7l0c
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900